IBR Inc. is a Non-clinical Contract Research Organisation (CRO) focused on integral services in biopharmaceutical analytics for the development of Biologics, Biosimilars and Vaccines. As founder of IBR Inc. Dr. Moser is CEO and CSO of the company since 1998.
Dr. René Moser promoted in medicine at the Medical Faculty of the University of Zurich. After training in experimental hematology, he constituted and directed the Laboratory of Inflammation Research as a senior research group leader at the Dept. of Internal Medicine, Hematology, University Hospital Zurich. His research focused on cellular mechanisms of inflammation with different seminal contributions in the field of leukocyte trafficking published in leading international journals. As senior research group leader at the Dept. of Pharmacy, ETH Zurich and the Institute of Toxicology, University and ETH, Zurich he further expanded his research and became private lecturer at the Medical Faculty of the University of Zurich.
We strive to meet our customer’s needs by providing high quality services at competitive prices. Continuous optimization of our structures and services is our commitment to maintain long term customer relationships, a prerequisite for growth and profit to our owners and employees.